Please login to the form below

Not currently logged in
Email:
Password:

Lighthouse Medical Communications appoints Andy Willmer as managing director

He will lead the Lucid Group's US company

Andy WillmerLucid Group subsidiary Lighthouse Medical Communications US has appointed Andy Willmer to head up its operations.

His new role will se him lead the communications agency in its delivery of medical education and disease understanding programmes, publications and communications planning, peer-to-peer medical communications and medical advocacy development.

He said: “I’m thrilled to be leading such a smart and dynamic team. The Lighthouse approach of building strategic medical communications which can change lives is rewarding and where I want to be.”

Following several senior roles within Pharmacia, Biovail and Roche, Willmer brings pharmaceutical, healthcare marketing and brand communications experience to the agency.

His most recent position was with Oglivy CommonHealth in the US, where he was general manager, medical marketing.

Dennis O’Brien, CEO and co-founder of Lucid, said: “Andy is a great fit with the team – and his history and experience in US and global pharma communications, both agency and client side, made him the ideal choice to head the Lighthouse Communications team in the US.

“Andy shares our passion to create magical programmes that transform patients’ lives by improving outcomes.”

17th October 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics